ADVERTISEMENT

ADVERTISEMENT

Brief Overview of The Trianni Mouse Platform

TRIANNI's antibody discovery platform, The Trianni Mouse, represents best-in-class technology for efficient generation of fully-human monoclonal antibodies.

TRIANNI’s antibody discovery platform, The Trianni Mouse, represents best-in-class technology for efficient generation of fully-human monoclonal antibodies.

For further information please click here: http://www.trianni.com

© european biotechnology

6 March 2018

YOU MIGHT ALSO LIKE

New operations of Vetter Pharma are planned in Saarlouis to be ready in 2031

Vetter: a multi-million-euro investment for new CDMO facility boost for Saarland/Germany

With an initial investment of around €480 million, Ravensburg-based Vetter Pharma has now fleshed out its plans to expand operations in Saarlouis, Saarland. The former automotive site is to be redeveloped … more ➔

ADC structure. In ATACs the cytotoxic payload is alpha-amanitin.

International Journal of Molecular Sciences, doi: 10.3390/ijms17040561 JO - s

Antibody drug conjugates

After a turbulent phase: a new milestone from Takeda for Heidelberg Pharma

Positive signals from a partnership with Takeda are allowing Heidelberg Pharma to push the setback from a milestone payment not received as planned from Telix somewhat into the background. Nevertheless, … more ➔

Tenpoint eye drop approval FDA

Tenpoint wins FDA approval for presbyopia eye drop and raises $235 million

It’s a busy day for U.K.-based Tenpoint Therapeutics, which has secured U.S. Food and Drug Administration (FDA) approval for YUVEZZI, a combination eye drop for the treatment of presbyopia, while raising … more ➔

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!